Fermented Whey Protein Produces Peptides That May Lower Blood Pressure and Fight Inflammation

Whey protein concentrate was co-fermented with Lactobacillus paracasei (at 37°C) and Saccharomyces cerevisiae (at 25°C) at varying time points and inoculation rates. Bioactive peptides were separated using RP-HPLC and identified by mass spectrometry. ACE inhibition, antioxidant activity, and anti-inflammatory effects were tested in vitro. Anti-inflammatory activity was assessed on RAW 264.7 macrophages stimulated with LPS. Molecular docking simulated peptide-enzyme interactions.

Whey protein is already one of the most widely consumed protein supplements. This study shows that fermenting it with specific bacteria and yeast produces bioactive peptides that could lower blood pressure, fight oxidative stress, and reduce inflammation — potentially turning a common protein supplement into a functional food with cardiovascular benefits.

This study is part of a growing field called food-derived bioactive peptides, where researchers look for drug-like compounds hidden in common foods. Dairy-derived ACE-inhibitory peptides (like those in fermented milk) have been studied for decades, and some have made it into commercial products. This work adds whey protein fermentate to the list of potential sources for naturally-derived blood pressure-lowering peptides.

Entirely in vitro and in silico — no animal or human studies. ACE inhibition in a test tube doesn't guarantee blood pressure reduction in people. The peptides may be digested before reaching their targets when consumed orally. Molecular docking predicts binding but doesn't confirm biological activity in vivo.